MedPath
NMPA Approval

Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets

H20180056

September 11, 2018

Drug Information

丁丙诺啡纳洛酮舌下片

片剂

丁丙诺啡8mg/纳洛酮2mg(均以碱基计)

化学药品

September 11, 2018

September 10, 2023

Company Information

Applicant Company

103-105 Bath Road, Slough, Berkshire SL1 3UH, United Kingdom

Manufacturing Company

Dansom Lane, Hull,East Yorkshire HU8 7DS, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

丁丙诺啡纳洛酮舌下片 - NMPA 批准文号 | MedPath